Assessing Ocular Surface Changes After Changing Glaucoma Medications
NCT00554411
·
clinicaltrials.gov ↗
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Monotherapy With Xalatan From 1 to 18 Months
Ocular Surface Disease
Sponsor
University of Colorado, Denver